Taochao Tan
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The development of novel chimeric antigen receptor gamma-delta T cells against multiple myeloma and single-cell RNA sequencing analysis.
Journal: British journal of haematology
Published: August 29, 2025
Human single domain antibody-based CAR-T cells targeting BAFF-R demonstrate promising preclinical activity in B-cell malignancies.
Journal: BMC cancer
Published: November 07, 2024
Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms.
Journal: British journal of haematology
Published: April 30, 2024
Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells.
Journal: JCI insight
Published: December 20, 2023
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial.
Journal: Nature medicine
Published: December 20, 2023
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape.
Journal: Signal transduction and targeted therapy
Published: August 12, 2021
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 13, 2021
Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy.
Journal: Journal of cellular physiology
Published: August 19, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026